Bacteriophage therapy and the mutant selection window.

Benjamin J Cairns, Robert J H Payne
Author Information
  1. Benjamin J Cairns: Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX37LF, United Kingdom. ben.cairns@ceu.ox.ac.uk

Abstract

We use kinetic models to investigate how to design antimicrobial phage therapies to minimize emergence of resistant bacteria. We do this by modifying the "mutant selection window" hypothesis in a way that accounts for the ongoing self-replication of the phage. We show that components of combination phage therapies need to be appropriately matched if treatment is to avoid the emergence of resistant bacteria. Matching of components is more easily achieved when phage dosages are high enough that ongoing phage replication is not needed for the clearance of the bacteria. Theoretical predictions such as ours need to be tested experimentally if applications of phage therapy are to avoid the problems of widespread resistance that have beset chemical antibiotics.

References

  1. Antimicrob Agents Chemother. 1999 Jul;43(7):1756-8 [PMID: 10390236]
  2. Clin Pharmacol Ther. 2000 Sep;68(3):225-30 [PMID: 11014403]
  3. Microb Ecol. 2000 Aug;40(2):114-124 [PMID: 11029080]
  4. J Theor Biol. 2001 Jan 7;208(1):37-48 [PMID: 11162051]
  5. Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S147-56 [PMID: 11524712]
  6. J Infect Dis. 2002 Feb 15;185(4):561-5 [PMID: 11865411]
  7. Clin Pharmacokinet. 2003;42(4):315-25 [PMID: 12648024]
  8. Nat Rev Drug Discov. 2003 Jun;2(6):489-97 [PMID: 12776223]
  9. Appl Environ Microbiol. 2003 Aug;69(8):4519-26 [PMID: 12902237]
  10. Appl Microbiol Biotechnol. 2004 Apr;64(2):270-4 [PMID: 13680205]
  11. J Theor Biol. 2004 Mar 7;227(1):1-11 [PMID: 14969703]
  12. BMJ. 2004 Mar 20;328(7441):668 [PMID: 14996699]
  13. Nat Rev Microbiol. 2004 Feb;2(2):166-73 [PMID: 15040264]
  14. Appl Environ Microbiol. 2004 Jun;70(6):3417-24 [PMID: 15184139]
  15. Ann Pharmacother. 2004 Oct;38(10):1675-82 [PMID: 15340128]
  16. J Biosci Bioeng. 2005 Sep;100(3):280-7 [PMID: 16243277]
  17. Trends Biotechnol. 2006 May;24(5):212-8 [PMID: 16567009]
  18. Appl Environ Microbiol. 2006 Jun;72(6):3908-15 [PMID: 16751496]
  19. Appl Environ Microbiol. 2006 Jul;72(7):5073-6 [PMID: 16820508]
  20. J Appl Microbiol. 2006 Jul;101(1):251-9 [PMID: 16834613]
  21. Antimicrob Agents Chemother. 2007 Jun;51(6):1934-8 [PMID: 17387151]
  22. Int J Antimicrob Agents. 2007 Aug;30(2):118-28 [PMID: 17566713]
  23. PLoS Pathog. 2007 Aug 24;3(8):e119 [PMID: 17722979]
  24. PLoS Pathog. 2009 Jan;5(1):e1000253 [PMID: 19119417]
  25. Expert Rev Respir Med. 2007 Aug;1(1):7-16 [PMID: 20477259]
  26. Fed Regist. 2016 Apr 15;81(73):22176-83 [PMID: 27101640]
  27. Appl Environ Microbiol. 1985 Jan;49(1):19-23 [PMID: 3156556]
  28. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3188-92 [PMID: 8622911]
  29. J Infect. 1998 Jan;36(1):5-15 [PMID: 9515662]

Grants

  1. BB/C504543/1/Biotechnology and Biological Sciences Research Council
  2. BB/C504578/1/Biotechnology and Biological Sciences Research Council

MeSH Term

Bacteria
Bacterial Infections
Bacteriophages
Humans
Listeria monocytogenes
Listeriosis
Models, Biological
Mutation
Selection, Genetic

Word Cloud

Created with Highcharts 10.0.0phagebacteriatherapiesemergenceresistantselectionongoingcomponentsneedavoidtherapyusekineticmodelsinvestigatedesignantimicrobialminimizemodifying"mutantwindow"hypothesiswayaccountsself-replicationshowcombinationappropriatelymatchedtreatmentMatchingeasilyachieveddosageshighenoughreplicationneededclearanceTheoreticalpredictionstestedexperimentallyapplicationsproblemswidespreadresistancebesetchemicalantibioticsBacteriophagemutantwindow

Similar Articles

Cited By (28)